Endocrinologia Clínica (Lúcio Vilar) - 6 Edição_Parte553

Prévia do material em texto

29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
Guglielmi R, Pacella CM, Bianchini A et al. Percutaneous ethanol injection treatment in benign thyroid lesions: role and
efficacy. Thyroid. 2004; 14:125-31.
Solymosi T, Gal I. Treatment of recurrent nodular goiters with percutaneous ethanol injection: a clinical study of twelve
patients. Thyroid. 2003; 13:273-7.
Perez CL, Fighera TM, Miasaki F et al. Evaluation of percutaneous ethanol injections in benign thyroid nodules. Arq Bras
Endocrinol Metabol. 2014; 58:912-7.
Monzani F, Del Guerra P, Caraccio N et al. Appearance of Graves’ disease after percutaneous ethanol injection for the
treatment of hyperfunctioning thyroid adenoma. J Endocrinol Invest. 1997; 20:294-8.
Pacella CM, Bizzarri G, Spiezia S et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology. 2004;
232:272-80.
Baek JH, Lee JH, Valcavi R et al. Thermal ablation for benign thyroid nodules: radiofrequency and laser efficacy. Korean J
Radiol. 2011; 12:525-40.
Krohn K, Fuhrer D, Bayer Y et al. Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev. 2005;
26:504-24.
Graf H. Multinodular goiter: pathogenesis and management. In: Braverman LE, Cooper DS (Ed.). Werner & Ingbar’s the
thyroid: a fundamental and clinical text. Philadelphia: Lippincott Williams & Wilkins, 2013. p. 635-49.
Erickson D, Gharib H, Li H et al. Treatment of patients with toxic multinodular goiter. Thyroid. 1998; 8:277-82.
Nygaard B, Hegedüs L, Ulriksen P et al. Radioiodine therapy for multinodular toxic goiter. Arch Intern Med. 1999;
159:1364-8.
Holm LE, Lundell G, Israelsson A et al. Incidence of hypothyroidism occurring long after iodine-131 therapy for
hyperthyroidism. J Nucl Med. 1982; 23:103-7.
Quérat C, Germain N, Dumollard JM et al. Surgical management of hyperthyroidism. Eur Ann Otorhinolaryngol Head Neck
Dis. 2015; 132:63-6.
Hamburger JI, Hamburger SW. Diagnosis and management of large toxic multinodular goiters. J Nucl Med. 1985; 26:888-
92.
Graf H. Recombinant human TSH and radioactive iodine therapy in the management of benign multinodular goiter. Eur J
Endocrinol. 2015; 172:R47-52.
Huysmans DA, Nieuwlaat WA, Erdtsieck RJ et al. Administration of a single low dose of recombinant human thyrotropin
significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab. 2000; 85:3592-6.
Nieuwlaat WA, Hermus AR, Sivro-Prndelj F et al. Pretreatment with recombinant human TSH changes the regional
distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab. 2001; 86:5330-6.
Nieuwlaat WA, Huysmans DA, van den Bosch HC et al. Pretreatment with a single, low dose of recombinant human
thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab. 2003;
88:3121-9.
Graf H, Fast S, Pacini F et al. Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131I) therapy
in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study. J Clin
Endocrinol Metab. 2011; 96:1368-76.
Fast S, Hegedüs L, Grupe P et al. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows
major reduction of the radiation burden with retained efficacy. J Clin Endocrinol Metab. 2010; 95:3719-25.
Albino CC, Graf H, Paz-Filho G et al. Radioiodine plus recombinant human thyrotropin do not cause acute airway
compression and are effective in reducing multinodular goiter. Braz J Med Biol Res. 2010; 43:303-9.
Albino CC, Mesa CO, Olandoski M et al. Recombinant human thyrotropin as adjuvant in the treatment of multinodular
goiters with radioiodine. J Clin Endocrinol Metab. 2005; 90:2775-80.
Albino CC, Graf H, Sampaio AP et al. Thiamazole as an adjuvant to radioiodine for volume reduction of multinodular
goiter. Expert Opinion on Investigational Drugs. 2008; 17:1781-6.
Flores-Rebollar A, Ruiz-Juvera A, Lopez-Carrasco G et al. Effect of 1110MBq radioiodine in reducing thyroid volume in
multinodular goiter: a new protocol. J Clin Med Res. 2013; 5:234-8.
Kyrilli A, Tang BN, Huyge V et al. Thiamazole pretreatment lowers the (131)I activity neeeded to cure hyperthyroidism in
patients with nodular goiter. J Clin Endocrinol Metab. 2015; 100:2261-7.
	Endocrinologia Clínica (Lúcio Vilar) - 6ª Edição